NFS-05

N/A

Report date: 2023/10/26 17:03:55

Base Information

Drug NameNFS-05
Drug Alias NameNFS-05NFS05rAAV2-OPA1
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionGene transference
TargetsNot applicable
Therapy Area/IndicationsOptic Atrophy, Autosomal Dominant
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPreclinical
Originator CompaniesWuhan Neurophth Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesWuhan Neurophth Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsOptic Atrophy, Autosomal Dominant
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A